The Vanguard Group, Inc. has recently announced that it has increased stake in Moderna Inc (NASDAQ:MRNA) by 0.67%. After grabbing 26.29 million shares, the institutional investor is now in possession of 0.18 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.90% having worth around $2.61 billion. Moreover, BlackRock Fund Advisors increased its share by 51608.0 to have a control over 16.53 million shares. And Thélème Partners LLP raised its holdings to 0.65 million shares by acquiring 6.9 million shares or 1.81% of the stake.
Moderna Inc (MRNA) concluded trading on Thursday at a closing price of $102.81, with 2.68 million shares of worth about $275.62 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -14.79% during that period and on Thursday, January 25 the price saw a gain of about 1.68%. Currently the company’s common shares owned by public are about 385.00M shares, out of which, 331.48M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 291 times over the past 12 months. They bought 1,754,003 shares in 65 of the transactions. In 226 selling transactions, insiders dumped 1,901,443 shares.
Vanguard Total Stock Market ETF, Vanguard International Growth Fun, and Scottish Mortgage Investment Trus are the top 3 mutual funds which are holding stakes in Moderna Inc Vanguard Total Stock Market ETF is currently holding 10.8 million shares of worth totaling $1.07 billion. The company recently came buying 0.66 million shares which brought its stake up to 2.83% of the company’s outstanding shares. Scottish Mortgage Investment Trus, after buying 9.2 million shares, have now control over 2.41% of the stake in the company. It holds 0.0 shares of worth $915.25 million.
However, the stock later moved at a day high price of 103.82, or with a gain of 1.68%. Stock saw a price change of 3.78% in past 5 days and over the past one month there was a price change of 8.35%. Year-to-date (YTD), MRNA shares are showing a performance of 3.38% which decreased to -47.75% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $62.55 but also hit the highest price of $195.00 during that period. The average intraday trading volume for Moderna Inc shares is 5.15 million. The stock is currently trading -1.57% below its 20-day simple moving average (SMA20), while that difference is up 14.38% for SMA50 and it goes to -5.07% lower than SMA200.
The Vanguard Group, Inc. acquired 26.29 million shares of Moderna Inc having value of about $2.61 billion. Data submitted at the U.S SEC by The Vanguard Group, Inc. revealed that the firm now holds 0.18 million shares in the company valued at close to $18092709.42, or have control over 0.67% stake in the company. Moderna Inc (NASDAQ: MRNA) currently have 385.00M outstanding shares and institutions hold larger chunk of about 63.25% of that. Holding of mutual funds in the company is about 22.94% while other institutional holders and individual stake holders have control over 40.61% and 13.63% of the stake respectively.
The stock has a current market capitalization of $39.20B and its 3Y-monthly beta is at 1.68. It has posted earnings per share of -$9.34 in the same period. It has Quick Ratio of 2.35 while making debt-to-equity ratio of 0.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MRNA, volatility over the week remained 3.45% while standing at 4.90% over the month.
Analysts are in expectations that Moderna Inc (MRNA) stock would likely to be making an EPS of -$1.12 in the current quarter, while forecast for next quarter EPS is -$2.83 and it is -$6.86 for next year. For the current quarter EPS, analysts have given the company a lowest target -$2.86 which is $3.38 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $3.61 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -167.37% while it is estimated to increase by 49.02% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Oppenheimer on January 02, 2024 offering an Outperform rating for the stock and assigned a target price of $142 to it.
